Application Nr Approved Date Route Status External Links
ANDA091525 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications For Use As An Adjunct In The Therapy Of All Forms Of Parkinsonism (See Dosage And Administration ). Useful Also In The Control Of Extrapyramidal Disorders (Except Tardive Dyskinesia — See Precautions ) Due To Neuroleptic Drugs (E.g., Phenothiazines).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Benztropine Mesylate BENZTROPINE MESYLATE ZINC100036536

Comments